|
|
Article: Advanced Stent Technologies, Inc. Announces Commencement Of U.S. Pivotal Study of Its SLK-View(TM) Stent and Delivery System to Treat Coronary Bifurcation Lesions.
- Article from:
- PR Newswire
- Article date:
- April 7, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
PLEASANTON, Calif. -- PLEASANTON, Calif., April 7 /PRNewswire/ -- Advanced Stent Technologies, Inc. (AST) announced today that it received approval from the U.S. Food and Drug Administration (FDA) to commence a pivotal study of its SLK-View(TM) stent and delivery system. The study, named "Bifurcation Optimized with the SLK-View(TM) Stent," or "BOSS," will utilize the SLK-View(TM) stent and delivery system to provide side branch access while treating coronary bifurcation lesions.
AST management anticipates that the first patient will be enrolled in the study during the week of April 7, 2003.
Following completion of the BOSS pivotal study and follow-up ...
Related newspaper, magazine, and journal articles:
|
|
Article: Advanced Stent Technologies, Inc. Chairman/Chief ...
PR Newswire;
April 23, 2003 ;
700+ words
... ... cardiologist, and Advanced Stent Technologies, Inc ... work full-time for Advanced Stent Technologies, Inc ... over-the-wire delivery system. Dr. Alan C. Yeung ... systems." About AST Advanced Stent Technologies, Inc ...
|
|